Available 7 Days/Week       MON - FRI  8am - 7pm       SAT - SUN  10am – 6pm
Call us (239) 466-0400
Apply Now

Another Johnson & Johnson COVID-19 vaccine side effect possible

FORT MYERS, Fla. — The Centers for Disease Control and Prevention recommended pausing the Johnson & Johnson coronavirus vaccine last week to investigate a potential connection to a rare blood clotting disorder.

More than 7,000,000 people have received the J&J shot and rare blood clots were only reported in six women.

The European Medicines agency said yesterday that a warning about unusual blood clots and low blood platelets should be added to the vaccine.

Local medical professionals are emphasizing that low platelet counts are just another side effect and are not what caused the six women to develop the clotting disorder.

“In this particular case, these were normal people,” Dr. Perez-Trepichio, Chief Medical Officer at Millennium Physician Group, said. “This is a very rare and very severe, but uncommon scenario, so we should not stop vaccinating.”

If you got the J&J vaccine between six and 13 days ago, call your doctor if you experience headaches, abdominal pain or leg pain.

Dr. Perez-Trepichio said that he thinks the J&J shot will be back on the market in the U.S. within the next few days, but with some restrictions.

The post Another Johnson & Johnson COVID-19 vaccine side effect possible appeared first on NBC2 News.

NBC2 (WBBH-TV)

#marcoislandmortgage, #marcoislandmortgagerates, #mortgagemarcoisland, *Top News, Covid, covid-19 vaccine, Health, Johnson & Johnson, News, side effects

Copyright © 2022 Fidelity Home Group supports Equal Housing Opportunity | All Right Reserved  | NMLS Identifier 1834853. Fidelity Home Group is not affiliated with the Department of Housing and Urban Development (HUD) or the Federal Housing Administration (FHA). Not intended for legal or financial advice, consult your own professionals if such advice is sought. Accessibility Statement  | Consent to Receive Electronic Loan Documents  |  Cookies Policy   |  Disclosures  | Email and Mobile PolicyFair Lending Policy  |  Mortgage Assumptions  |  NMLS Consumer Access  |  Privacy Policy  |  Terms of Use